For Healthcare Professionals

A Study to Explore the Incidence of Influenza and Respiratory Syncytial Virus (RSV) in Adults Hospitalized With Acute Respiratory Tract Infection

clipboard-pencil

About the study

The purpose of the main study is to describe the incidence of influenza virus and respiratory syncytial virus (RSV) in adults hospitalized with acute respiratory tract infection (ARTI) during the influenza/RSV season, and the purpose of the substudy is to describe the clinical and economic burden in adults hospitalized with confirmed influenza/RSV infection.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

Main Study:

  1. Participants (or their legally acceptable representative) who signed an informed consent form
  2. Hospitalized
  3. Participants with clinical diagnosis of acute respiratory tract infection (ARTI) during the influenza/respiratory syncytial virus (RSV) season, with or without associated complications or other diseases (such as, but not limited to: acute exacerbation of asthma or chronic obstructive pulmonary disease [COPD], malignancy, hypoxemia, congestive heart failure, sepsis, septic shock, pregnancy, immunodeficiencies) Substudy:
  4. Participants with confirmed diagnosis of influenza and/or RSV infection using a PCR-based influenza/RSV test

EXCLUSION CRITERIA

Main study and Substudy:

  1. Participants who participated in another clinical study, with the exception of registry and epidemiology studies involving minimum sampling done prior to the participant screening for the proposed study
  2. Participants not able to comply with study-related procedures, due to their mental status or severe clinical condition, based on clinical judgement of the investigator
  3. Participants who received an experimental RSV vaccine
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 844-434-4210Email iconEmail Study Center

Study’s details


Contition

Respiratory Tract Infections

Age (in years)

18 - 200

Phase

N/A

Participants needed

5000

Est. Completion Date

Feb 2020

Treatment type

Observational


Sponsor

Janssen Research & Development, LLC

ClinicalTrials.gov identifier

NCT03148405

Study number

NoProdRSV0006

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.